Management of liver disease in Nigeria

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 7, Issue 5, 2007, Pages 439-441

  Ladep, Nimzing G ^a   Taylor Robinson, Simon D ^b,c  

^a UNIVERSITY OF JOS   (Nigeria)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Band ligation; Endoscopy; Healthcare; Hepatocellular carcinoma; Liver disease; Nigeria; Oesophageal varices; Viral hepatitis

Indexed keywords

ANTIVIRUS AGENT; LAMIVUDINE;

DEMOGRAPHY; DRUG COST; ENDOSCOPY; ESOPHAGUS VARICES; HEALTH CARE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER DISEASE; NIGERIA; PREVALENCE; SHORT SURVEY; TRAINING; UNITED KINGDOM;

EID: 35748939995     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.7-5-439     Document Type: Short Survey

References (20)

1. Central Intelligence Agency. CIA world fact book. Washington, DC: CIA, 2006. www.cia.gov/cia/publications/factbook/geos/ni.html
2. African Union. www.africa-union.org
3. Nigeria Direct. www.nigeria.gov.ng
4. Federal Ministry of Health. Nigeria: revised national health policy. Abuja: Federal Ministry of Health, 2004:4-6.
5. Amazigo UO, Chime AB. Hepatitis-B virus infection in rural and urban populations of eastern Nigeria: prevalence of serological markers. East Afr Med J 1990;67:539-44.
6. Onyekwere CA, Anomneze EE, Wali EE. Prevalence of serological markers of chronic hepatitis B virus infection in diabetics in the Lagos University Teaching Hospital, Lagos. Niger Postgrad Med J 2002;9:129-33.
7. Bojuwoye BJ. The burden of viral hepatitis in Africa. West Afr J Med 1997;16:198-203.
8. Olubuyide IO. The natural history of primary liver cell carcinoma: a study of 89 untreated adult Nigerians. Cent Afr J Med 1992;38:25-30.
9. Ndububa DA, Ojo OS, Adeodu OO et al. Primary hepatocellular carcinoma in Ile-Ife, Nigeria: a prospective study of 154 cases. Niger J Med 2001;10:59-63.
10. Koate BB, Buseri FI, Jeremiah ZA. Seroprevalence of hepatitis C virus among blood donors in Rivers State, Nigeria. Transfus Med 2005;15:449-51.
11. Halim NK, Ajayi OI. Risk factors and seroprevalence of hepatitis C antibody in blood donors in Nigeria. East Afr Med J 2000;77:410-2.
12. Ejele OA, Nwauche CA, Erhabor O. Seroprevalence of hepatitis C virus in the Niger Delta of Nigeria. Niger J Med 2006;13:103-6.
13. Lesi OA, Kehinde MO. Hepatitis C virus infection in patients with sickle cell anaemia at the Lagos University Hospital. Niger Postgrad Med J 2003;10:79-83
14. 31P MR spectroscopy to histology in chronic hepatitis C. Hepatology 2003;37:788-94.
15. Chappell KE, Patel N, Gatehouse PD et al. Magnetic resonance imaging of the liver with ultrashort TE (UTE) pulse sequences. J Magn Reson Imaging 2003;18:709-13.
16. Lim AK, Taylor-Robinson SD, Patel N et al. Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C. Gut 2005;54:128-33
17. Cobbold J, Lim A, Wylezinska M et al. Magnetic resonance and ultrasound techniques for the evaluation of hepatic fibrosis. Hepatology 2006;43:1401-2.
18. Ola SO, Anomneze EE, Chukwuani CM et al. Interferon alfa-2a (Roferon-A) in the management of chronic hepatitis B infection: results of an open prospective study in Nigeria patients. West Afr J Med 2000;19:259-64.
19. Agwale SM, Tanimoto L, Womack C et al Prevalence of HCV coinfection in HIV-infected individuals in Nigeria and characterization of HCV genotypes. J Clin Virol 2004;31(Suppl 1): S3-6.
20. The Tropical Health and Education Trust. www.thet.org.uk